Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ccd25cf2e8d9d4135ca70051591a1e4 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343 |
filingDate |
2010-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f69f681d7d01c3e3011e40264ea12653 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd66f18fd895e140545c7be42c837c46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da176f655d3cabfcadf1b70a8a504db5 |
publicationDate |
2011-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
TW-201132342-A |
titleOfInvention |
Antrocin containing pharmaceutical compositions for inhibiting cancer cells |
abstract |
This subject invention is directed to a pharmaceutical composition for the inhibition of cancer cells, comprising an effective amount of a compound of formula I (Sesquiterpene lactones, antrocin) or pharmaceutical acceptable salts thereof, together with a pharmaceutically acceptable carrier. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I778414-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I417289-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109700799-A |
priorityDate |
2010-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |